Tourmaline Bio, Inc. (TRML)
47.98
0.00 (0.00%)
USD |
NASDAQ |
Dec 11, 16:00
Tourmaline Bio Free Cash Flow: -86.30M for June 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Novartis AG | 17.15B |
| Merck & Co., Inc. | 13.05B |
| UnitedHealth Group, Inc. | 17.37B |
| Gilead Sciences, Inc. | 9.162B |
| Eli Lilly & Co. | 6.436B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.26M |
| Cash from Investing (Quarterly) | 16.30M |
| Cash from Financing (Quarterly) | 0.054M |
| Free Cash Flow Per Share (Quarterly) | -0.7871 |
| Free Cash Flow to Equity (Quarterly) | -20.22M |
| Free Cash Flow to Firm (Quarterly) | -20.27M |
| Free Cash Flow Yield | -6.98% |